Oxymetazoline hydrochloride 0.1% ophthalmic solution has Food & Drug Administration (FDA) approval for use in involution ptosis. It is an alpha 1 agonist and partial...
The purpose of this study was to evaluate the effect of the Bernell EYEPORT II vision training system on accommodation in cases of accommodative insufficiency...
The authors present the results of two surgical approaches to treat exotropia Duane’s retraction syndrome (DRS) with significant overshoot and retraction. This study compared single...
The aim of this study was to assess the perspectives and concerns of parents in relation to exotropia surgery in comparison to how clinicians predicted...
The authors present a cohort study of 326 patients with simple central serous chorioretinopathy (CSC) according to the classification system laid down by Chhablani, et...
This is a review article summarising the latest myopic CNV (choroidal neovascularisation) literature in the clinical experience and management outcomes for recommendation algorithm. The aetiology...
This is a retrospective, population-based, case-control study from the general Kaiser Hawaii population. Over a two year period (1 January 2006 to 31 December 2007),...
Continuous wave cyclophotocoagulation (CWCPC) delivers continuous high intensity energy to the ciliary body in an attempt to reduce aqueous secretion and hence lower IOP. It...
This is a retrospective case series of chart review of patients who had silicone band loop myopexy between January 2008 to December 2012 for myopic...
Visual vertigo is a disorder characterised by symptoms of dizziness, vertigo, unsteadiness, disorientation and general discomfort induced by visual triggers. It is currently treated with...